Moving CLABSI prevention beyond the intensive care unit: Risk factors in pediatric oncology patients

Infection Control and Hospital Epidemiology

Volumn 32, Issue 11, 2011, Pages 1079-1085

  Kelly, Matthew ^a   Conway, Margaret ^a   Wirth, Kathleen ^b   Potter Bynoe, Gail ^a   Billett, Amy L ^a,c   Sandora, Thomas J ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BACTERIUM ISOLATE; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; FEMALE; GRAM POSITIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; STEM CELL TRANSPLANTATION; THROMBOCYTE TRANSFUSION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADOLESCENT; ADULT; CANDIDIASIS; CASE-CONTROL STUDIES; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; ONCOLOGY SERVICE, HOSPITAL; PLATELET TRANSFUSION; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; TIME FACTORS; VANCOMYCIN RESISTANCE; YOUNG ADULT;

EID: 80054860603     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/662376     Document Type: Article

References (40)

1. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Morb Mortal Wkly Recomm Rep 2002;51(RR-10):1-29.
2. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-1601.
3. Biwersi C, Hepping N, Bode U, et al. Bloodstream infections in a German paediatric oncology unit: prolongation of inpatient treatment and additional costs. Int J Hyg Environ Health 2009; 212:541-546.
4. Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med 2009;37:2283-2289.
5. Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115:868-872.
6. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37: 783-805.
7. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-365.
8. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53-58.
9. Ross MN, Haase GM, Poole MA, Burrington JD, Odom LF. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988;167:141-144.
10. Smith TL, Pullen GT, Crouse V, Rosenberg J, Jarvis WR. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge. Infect Control Hosp Epidemiol 2002; 23:239-243.
11. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014-2020.
12. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006;355:2725-2732.
13. Costello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008; 121:915-923.
14. Miller MR, Griswold M, Harris JM, et al. Decreasing PICU catheter-associated bloodstream infections: NACHRI's quality transformation efforts. Pediatrics 2010;125:206-213.
15. Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009;30:645-651.
16. Chelliah A, Heydon KH, Zaoutis TE, et al. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Pediatr Infect Dis J 2007;26:816-820.
17. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconateimpregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431-1436.
18. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 2006;43:474-484.
19. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309-332.
20. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
21. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304:2035-2041.
22. Niedner MF, 2008 National Association of Children's Hospitals and Related Institutions Pediatric Intensive Care Unit Patient Care Focus Group. The harder you look, the more you find: catheter-associated bloodstream infection surveillance variability. Am J Infect Control 2010;38:585-595.
23. Fuller AK, Uglik KM, Savage WJ, Ness PM, King KE. Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single-donor platelets. Transfusion 2009;49: 2588-2593.
24. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/suppressor ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308-310.
25. Wood ML, Gottschalk R, Monaco AP. Effect of blood transfusion on IL-2 production. Transplantation 1988;45:930-935.
26. Waymack JP, Gallon L, Barcelli U, Alexander JW. Effect of blood transfusions on macrophage function in a burned animal model. Curr Surg 1986;43:305-307.
27. Aslam R, Speck ER, Kim M, Freedman J, Semple JW. Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells. Transfusion 2008;48:1778-1786.
28. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell: CD40 ligand and transfusion immunomodulation. Immunol Res 2009;45:251-260.
29. Blumberg N, Heal JM. Effects of transfusion on immune function: cancer recurrence and infection. Arch Pathol Lab Med 1994; 118:371-379.
30. Houbiers JG, van de Velde CJ, van de Watering LM, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion 1997;37:126-134.
31. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
32. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Eur J Cancer 1999;35:770-774.
33. Chathas MK, Paton JB, Fisher DE. Percutaneous central venous catheterization: three years' experience in a neonatal intensive care unit. Am J Dis Child 1990;144:1246-1250.
34. Casado-Flores J, Valdivielso-Serna A, Perez-Jurado J, et al. Subclavian vein catheterization in critically ill children: analysis of 322 cannulations. Intensive Care Med 1991;17:350-354.
35. Abbas AA, Fryer CJ, Paltiel C, et al. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study. Pediatr Blood Cancer 2004; 42:325-331.
36. Simon A, Ammann RA, Bode U, et al. Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 2008;8:70.
37. Stamou SC, Maltezou HC, Pourtsidis A, et al. Hickman-Broviac catheter-related infections in children with malignancies. Mt Sinai J Med 1999;66:320-326.
38. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16: 128-140.
39. DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 2005;41:327-333.
40. Butler AM, Olsen MA, Merz LR, et al. Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol 2010;31:28-35.